| Stage | MAR | % of rev | CHH | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.0B | 100.00% | $458M | 100.00% | MAR ×15.28 |
| Gross profit | $1.5B | 22.03% | $238M | 51.97% | CHH +29.9pp |
| Operating income | $1.3B | 18.19% | $106M | 23.23% | CHH +5.0pp |
| Pre-tax income | $1.1B | 15.13% | $75M | 16.37% | CHH +1.2pp |
| Net income | $794M | 11.33% | $58M | 12.64% | CHH +1.3pp |
| Stage | MAR | CHH | Gap · A − B |
|---|---|---|---|
| Revenue | $7.0B100.00% | $458M100.00% | MAR ×15.28 |
| Gross profit | 22.03%$1.5B | 51.97%$238M | CHH +29.9pp |
| Operating income | 18.19%$1.3B | 23.23%$106M | CHH +5.0pp |
| Pre-tax income | 15.13%$1.1B | 16.37%$75M | CHH +1.2pp |
| Net income |
| 11.33%$794M |
| 12.64%$58M |
| CHH +1.3pp |
No shared counterparties.